Quoin Pharmaceuticals, Ltd. (QNRX) Reports Q2 Loss of $3.24/sh
Tweet
Share
E-mailGet Alerts QNRX Hot Sheet
Join SI Premium – FREE
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q2 EPS of ($3.24), versus ($18.05) reported last year.
For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Traws Pharma (TRAW) Tops Q2 EPS by 27c
- LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
